EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT
Akil Merchant(University of Southern California), Parkash S. Gill(University of Southern California)
Cited by 24
Related Papers
Receptor Tyrosine Kinase EphB4 Is a Survival Factor in Breast Cancer
|American Journal Of Pathology|2006|190